SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-19-040598
Filing Date
2019-07-17
Accepted
2019-07-16 17:43:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-12882_4sc13da.htm SC 13D/A 48352
  Complete submission text file 0001104659-19-040598.txt   49792
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85963 | Film No.: 19957853
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Lo Andrew (Filed by) CIK: 0001679076 (see all company filings)

Type: SC 13D/A